Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Hepatitis C and Hepatitis B in Inpatients: A Toronto Viral Hepatitis Care Network (VIRCAN) Collaboration

NCT04620226 is registered in ClinicalTrials.gov with Jordan Feld as lead sponsor.

NCT NCT04620226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Hepatitis C and Hepatitis B in Inpatients: A Toronto Viral Hepatitis Care Network (VIRCAN) Collaboration
Lead sponsor
Jordan Feld
Phase
Phase 4
Overall status
Unknown status
Start date
February 1, 2024
Completion date
July 31, 2025
Enrollment
2,920 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatitis c